African tick-bite fever.
Division of Infectious Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.
Daniel Z
DZ
Uslan
Irene G
IG
Sia
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D004318:Doxycycline / Q000627:therapeutic use; D005076:Exanthema / Q000382:microbiology; D005334:Fever / Q000382:microbiology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008206:Lymphatic Diseases / Q000382:microbiology; D008295:Malawi / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008910:Minnesota; D012281:Rickettsia / Q000145:classification / Q000276:immunology; D012282:Rickettsia Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D017282:Tick-Borne Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D014195:Travel; D015024:Zambia / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D004318:Doxycycline